Beyond Treatment: How Diet & Exercise Can Empower Lymphoma Patients Through Chemotherapy – New research from Sylvester Thorough Cancer Center
For decades, the conversation around lifestyle and cancer has largely focused on prevention and survivorship. But what if optimizing nutrition and physical activity during cancer treatment could substantially improve outcomes? Groundbreaking research from Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, suggests it can. Presented at the American Society of Hematology (ASH) Annual Meeting, the LIFE-L study is challenging conventional wisdom and opening a new frontier in supportive cancer care.
The Missing Piece in Cancer Care: Addressing Lifestyle During Treatment
Historically, the impact of lifestyle interventions during chemotherapy has been a largely unexplored area. “A lot of the work that has been done in the area of lifestyle and oncology has been in the prevention setting or in the survivorship setting after treatment,” explains Dr. Romina Lopez, a key researcher on the LIFE-L study. This gap in knowledge is significant, as the debilitating side effects of chemotherapy frequently enough compromise a patient’s quality of life and, crucially, their ability too adhere to their prescribed treatment plan.
This is where the LIFE-L study steps in, offering a compelling argument for integrating proactive lifestyle support into the standard of care for lymphoma patients.
LIFE-L: A Rigorous Study Demonstrating Real-World Impact
Led by Tracy Crane, co-lead of the cancer Control Program and director of lifestyle medicine, prevention and digital health at Sylvester, and Craig Moskowitz, professor in the Hematology/Oncology Division at the Miller School and Sylvester director of academic clinician development, the LIFE-L study meticulously examined the effects of a virtual diet and exercise program on 72 individuals undergoing standard, six-cycle combination chemotherapy for lymphoma.
The study design was robust: 44 patients received immediate access to the program, while 28 were placed on a waitlist control group for comparison. The program wasn’t a one-size-fits-all approach. Instead, it provided personalized support through weekly online coaching sessions with a registered dietitian and an exercise physiologist, tailored to each patient’s unique needs and challenges.
High Engagement & Significant Symptom Reduction
A key concern before launching the study was feasibility. Could patients, already grappling with the physical and emotional toll of chemotherapy, realistically commit to a lifestyle intervention? The results were overwhelmingly positive. An extraordinary 81% of eligible patients enrolled, with consistently high attendance rates – 86% for diet sessions and 81% for exercise sessions. This demonstrates a clear patient desire for proactive support during treatment.
But engagement wasn’t just about showing up. The intervention group experienced significant reductions in key symptoms commonly associated with chemotherapy:
* Anxiety: 17% vs.34% in the waitlist group
* Depression: 46% vs. 67%
* Pain: 22% vs. 39%
* Fatigue: 46% vs. 67%
* Constipation: 17% vs. 25%
Beyond symptom management, participants in the intervention group also demonstrated improved physical function, exhibiting greater grip strength and superior performance on physical performance tests. These findings suggest that a targeted lifestyle program can not only alleviate suffering but also bolster a patient’s physical resilience during a challenging time.
The Critical Link Between Treatment Adherence & Survival
The LIFE-L study isn’t just about making patients feel better; it’s about improving their outcomes. Researchers are now focused on assessing whether reducing treatment burden – the cumulative impact of side effects – translates to better adherence to chemotherapy regimens.
“We know that if patients receive less than 85% of their prescribed chemotherapy, there are implications for survival,” emphasizes Dr. Lopez. “The goal is to keep patients above the 85% and, to do that, patients need to be healthy enough to be able to tolerate the dose that was prescribed.”
This highlights a crucial point: optimizing a patient’s physical and mental well-being during treatment isn’t a luxury; it’s a vital component of effective cancer care.
Bridging the Gap: Empowering Clinicians & Patients
Dr. Lopez and the Sylvester team recognize that translating research into practice requires a collaborative effort. They are actively working to educate hematologist-oncologists about the benefits of lifestyle medicine and the availability of programs like LIFE-L.
“It’s been very, very rewarding to see the physicians referring patients,” says Dr. Lopez. “The physicians are key stakeholders in all of
Worth a look